2021
DOI: 10.1016/j.bja.2020.10.036
|View full text |Cite
|
Sign up to set email alerts
|

Effects of noxious stimulation on the electroencephalogram during general anaesthesia: a narrative review and approach to analgesic titration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
45
1
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 57 publications
(61 citation statements)
references
References 95 publications
0
45
1
2
Order By: Relevance
“…49 While termed delta arousal, these delta responses may not necessarily imply the progression toward the restoration of consciousness. 48 In our experiments, the delta power and burst duration were increased after optical stimulation, suggesting cortical activation and a decrease in anesthesia depth, but we did not conclude that consciousness was restored after stimulation of the paraventricular thalamus during deep anesthesia with burst suppression. Another unexpected finding was that the activation of the paraventricular thalamus bed nucleus of the stria terminalis pathway was sufficient to induce behavioral arousal during light sevoflurane anesthesia maintenance, which was not seen in isoflurane anesthesia.…”
Section: Discussioncontrasting
confidence: 70%
“…49 While termed delta arousal, these delta responses may not necessarily imply the progression toward the restoration of consciousness. 48 In our experiments, the delta power and burst duration were increased after optical stimulation, suggesting cortical activation and a decrease in anesthesia depth, but we did not conclude that consciousness was restored after stimulation of the paraventricular thalamus during deep anesthesia with burst suppression. Another unexpected finding was that the activation of the paraventricular thalamus bed nucleus of the stria terminalis pathway was sufficient to induce behavioral arousal during light sevoflurane anesthesia maintenance, which was not seen in isoflurane anesthesia.…”
Section: Discussioncontrasting
confidence: 70%
“…Third, our spectrogram-based anesthetic titration algorithm was based on the idea that excessive (ie, supratherapeutic) volatile anesthetic dosage would result in a decrease in alpha band power and that lowering end-tidal MAC fraction in such cases would increase alpha power. This could be questioned based on data published after our study had started, 36 demonstrating that in contrast to prior studies, 13,14 alpha power decreases with increasing volatile anesthetic concentrations in roughly half of patients, while it increases with increasing volatile anesthetic dosage in the other half. Nonetheless, since alpha band peak frequency changes with anesthetic dosage, 36 it could be used to guide anesthetic titration in future studies.…”
Section: Anesthesia and Analgesiamentioning
confidence: 65%
“…This could be questioned based on data published after our study had started, 36 demonstrating that in contrast to prior studies, 13,14 alpha power decreases with increasing volatile anesthetic concentrations in roughly half of patients, while it increases with increasing volatile anesthetic dosage in the other half. Nonetheless, since alpha band peak frequency changes with anesthetic dosage, 36 it could be used to guide anesthetic titration in future studies. Fourth, our ELC did not cover EEG effects of neuromuscular blockade, nociceptive stimulation, opioids, or acute hypertension.…”
Section: Anesthesia and Analgesiamentioning
confidence: 65%
“…This is postulated to be due to thalamocortical interactions ( Vijayan et al, 2013 ), though its neurophysiological significance in relation to NCD remains unknown. Though there is limited published evidence on how to promote alpha power on EEG, reducing anesthetic depth ( Kreuzer et al, 2017 ) and providing adequate analgesia ( Garcia et al, 2021 ) have shown utility and have motivated an ongoing clinical trial to assess the intraoperative modulation of alpha power and its relation to POD ( clinicaltrials.gov identifier NCT04443517).…”
Section: Managementmentioning
confidence: 99%